AVR Stock Analysis: Buy, Sell, or Hold?
AVR - Anteris Technologies Global Corp. Common Stock
$9.36
-0.41 (-4.20%)
▼
5d:
-11.45%
30d:
-1.47%
90d:
+64.79%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 10, 2026
26d
Get Alerted When AVR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AVR is down 11.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AVR is down 11.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AVR is currently trading at $9.36, which is considered slightly low relative to its 30-day fair value range of $9.26 to $10.05.
Technical Outlook: Technically, AVR is in a strong uptrend. The price is currently testing key support at $9.28. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.33 (+63.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AVR is in a strong uptrend. The price is currently testing key support at $9.28. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.33 (+63.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.26 -
$10.05
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.2%)
- BULLISH: Trading 63.8% below Wall St target ($15.33)
- WARNING: Recommendation downgraded due to -11.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$9.26 -
$10.05
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$9.28
Resistance Level
$11.06
Current Trend
Strong Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.55
Wall Street Target
$15.33
(+63.8%)
Revenue Growth (YoY)
-11.2%
Share & Embed Analysis
Last updated: July 14, 2026 1:21 AM ET
Data refreshes hourly during market hours. Next update: 2:21 AM
Data refreshes hourly during market hours. Next update: 2:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
L1 Capital Pty Ltd
BUY
5000000 shares
2026-01-22
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$562 | 63 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 61 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$177 | 56 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$366 | 63 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 61 BUY |
